Safety, Immunogenicity, Long-term efficacy, Aerosolized Ad5-nCoV, Booster
Herpes zoster, postherpetic neuralgia, incidence
Varicella-Zoster Virus, Seroepidemiology, IgG Antibody, Influencing Factors